Introduction/Overview
8-Gingerol, as one of the important active ingredients in ginger (Zingiber officinale Roscoe), has attracted significant attention in recent years due to its diverse bioactivity and potential clinical applications. As a traditional Chinese medicine and seasoning spice, ginger is widely used in Asia and even worldwide, with pharmacological effects covering anti-inflammatory, antioxidant, anti-tumor, immunomodulatory, and cardiovascular protection. 8-Gingerol, as a typical class of phenolic and β-hydroxyketone compounds in ginger, exhibits a unique molecular structure and multi-target mechanism, making it a hot topic in natural product pharmacology research.
This paper aims to systematically review the chemical structure and physicochemical properties, plant origin, and extraction methods of 8-gingerol, delve into its pharmacological activity and mechanism of action, evaluate its druggability and pharmacokinetic characteristics, and anticipate its clinical application potential in cancer, infection, immunosuppression, and cardiovascular diseases. By integrating the latest research progress, it is hoped to provide theoretical basis and research directions for the drug development and clinical translation of 8-gingerol.
Chemical structure and physicochemical properties
8-Gingerol (CAS No.: 23513-08-8), chemically named (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)octanone, belongs to the monomethoxyphenol and β-hydroxy ketone compounds. Its molecular formula is C17H26O4, with a molecular weight of 322.44 g/mol. The structural features of 8-gingerol include a benzene ring with methoxy and hydroxyl substitutions, and a long-chain fat side chain containing hydroxyl and ketone groups. This structure gives it good lipid solubility and certain polarity.
In terms of physicochemical properties, the LogP value of 8-gingerol is about 4.26, indicating high lipid solubility, which facilitates its penetration through cell membranes. The polar surface area (TPSA) is 66.76 Ų, and the number of hydrogen bond acceptors is 4, indicating its potential for intermolecular hydrogen bond formation. 8-Scavengol has a low blood-brain barrier penetration capacity, suggesting limited direct impact on the central nervous system. Toxicity assessment showed no significant hepatotoxicity or cardiotoxicity, and did not inhibit hERG channels. Ames-induced mutagenic tests were negative, demonstrating good safety and drug potential.
Plant Origins and Extraction Methods
8-Scavengol is mainly found in the rhizome of ginger (Zingiber officinale Roscoe) and is an important class of ginger phenol compounds. As a traditional medicinal plant, ginger is widely distributed in China, India, Japan, and Southeast Asia. Its rhizomes contain various gingerol and gingerone compounds, with 8-gingerol being one of the most abundant and highly active components.
There are various methods for extracting 8-gingerol; traditional methods include solvent extraction, supercritical CO2 extraction, and liquid chromatography separation. Common solvents include ethanol, methanol, and ethyl acetate, which can effectively extract their fat-soluble components. Modern extraction technologies such as ultrasound-assisted extraction and microwave-assisted extraction have significantly improved extraction efficiency and purity. After extraction, high-performance liquid chromatography (HPLC) combined with mass spectrometry (MS) is typically used for qualitative and quantitative analysis to ensure the purity and active ingredient content of 8-gingerol.
Pharmacological activity research
Antioxidant and anti-inflammatory effects
8-Gingerol has significant antioxidant activity, effectively scavenging free radicals, lowering intracellular reactive oxygen species (ROS) and reactive sulfur (RS) levels, and protecting cells from oxidative stress damage. Its anti-inflammatory effects mainly manifest as inhibiting the expression and activity of cyclooxygenase-2 (COX-2), reducing the release of inflammatory mediators and thereby alleviating inflammatory responses. In vitro experiments have shown that 8-gingerol can inhibit the production of inflammatory factors by macrophages and other immune cells, while in vivo models show a relief effect on inflammation symptoms.
Immune regulation and immunosuppressive effects
8-Scavengol exerts immunosuppressive effects by inducing cell cycle arrest, promoting apoptosis, and regulating autophagy. Its regulation of immune cell function helps alleviate excessive immune responses and holds potential value in treating autoimmune and inflammatory diseases. Additionally, 8-gingerol can regulate various signaling pathways, influencing the proliferation and differentiation of immune cells, exhibiting complex immunomodulatory functions.
Antitumor activity
8-Scavengol exhibits the ability to inhibit proliferation, migration, and invasion across various tumor cell lines. Its anti-cancer mechanism involves inhibiting the epidermal growth factor receptor (EGFR) and its downstream STAT3 and ERK signaling pathways, inducing cancer cell apoptosis and blocking the cell cycle progression. Especially in colon cancer cells, 8-gingerol significantly inhibits tumor growth, suggesting its potential as an anticancer drug. Additionally, 8-gingerol enhances tumor cells' sensitivity to treatment by reducing oxidative stress and regulating cellular autophagy.
Skin whitening and inhibition of melanin production
8-Gingerol can inhibit melanin production, mainly by suppressing tyrosinase activity and the expression of related genes (MC1R, MITF, TRP1, TRP2), thereby reducing ROS levels in B16F10 and B16F1 melanocytes. Its mechanism involves downregulating the MAPK and protein kinase A (PKA) signaling pathways, thereby inhibiting melanin synthesis. This characteristic gives it promising applications in skin whitening and anti-pigmentation fields.
Antibacterial activity
8-Szgaolol exhibits in vitro inhibitory effects on Helicobacter pylori, suggesting its potential application value in the treatment of gastrointestinal infections. Its antimicrobial mechanism may be related to disrupting bacterial cell membrane structures and inhibiting key enzyme activities.
Cardioprotective effects
8-Gingerol exerts cardioprotective effects by antioxidant, anti-inflammatory, and regulating myocardial cell signaling pathways. Research shows that 8-gingerol can alleviate myocardial ischemia-reperfusion injury, improve cardiac function, and lower myocardial cell apoptosis rates, offering potential value in the prevention and treatment of cardiovascular diseases.
Mechanism of action and molecular targets
8-Sgingerol has diverse mechanisms of action, involving multiple signaling pathways and molecular targets:
- Antioxidant mechanism: By removing ROS and RS, it reduces oxidative stress and protects cells from oxidative damage.
- Anti-inflammatory mechanism: Inhibits COX-2 expression, reduces synthesis of inflammatory mediators such as prostaglandins, and lowers inflammatory response.
- Immune regulatory mechanism: induces cell cycle arrest, promotes apoptosis, and regulates autophagy, regulating immune cell function.
- Antitumor mechanism: Inhibits EGFR and its downstream STAT3/ERK signaling pathways, blocking tumor cell proliferation and migration.
- Melanin production inhibition mechanism: downregulates MC1R, MITF, tyrosinase, TRP1, and TRP2 expression, suppressing the MAPK and PKA signaling pathways.
- TRPV1 activation: 8-S-gingerol, as an agonist of the TRPV1 receptor, has an EC50 of about 5.0 μM and is involved in pain regulation and neuroprotection.
- Antibacterial mechanism: Directly inhibits H. Pylori growth may be achieved through cell membrane disruption and enzyme activity inhibition.
Additionally, the potential regulatory role of 8-gingerol in hyperglycemia-related targets (such as EHMT2, UBP2, PAI1, AMPK, SGLT2, GCK, APP, BACE1, CES1, PTPN1) suggests its research value in the field of metabolic diseases.
Druggability evaluation and pharmacokinetics
The druggability parameters of 8-gingerol indicate that it has promising potential for drug development. The molecular weight is moderate (322.44 g/mol), with a LogP value of 4.26, indicating good lipid solubility and membrane permeability. TPSA is 66.76 Ų, with 4 hydrogen bond acceptors, following the Lipinski rule and facilitating oral absorption. Toxicological evaluation showed no significant hepatotoxicity, cardiotoxicity, or genotoxicity, indicating a relatively high safety profile.
Pharmacokinetic studies have shown that 8-gingerol has good bioavailability after oral administration, effectively activating the TRPV1 receptor and exerting physiological effects. Its lower blood-brain barrier penetration reduces the risk of central nervous system side effects. The metabolic pathway mainly involves the liver enzyme system, with relatively stable metabolic products, and excretion mainly through bile and urine.
However, 8-gingerol has poor water solubility, limiting its bioavailability and in vivo distribution. In the future, pharmaceutical formulation improvements (such as nanocarriers and liposome encapsulation) are needed to enhance its pharmacokinetic performance.
Prospects and outlooks for clinical applications
Based on 8-gingerol's multi-target and multi-mechanism pharmacological activity, it shows broad application prospects across multiple disease fields:
- Cancer Treatment: By inhibiting the EGFR/STAT3/ERK signaling pathway and inducing cancer cell apoptosis, 8-gingerol is expected to become an adjunctive therapy for colon cancer and other solid tumors.
- Immune regulation: Its immunosuppressive and anti-inflammatory properties offer new strategies for treating autoimmune diseases and chronic inflammatory diseases.
- Skin diseases: Inhibits melanin production, showing potential for development into whitening and anti-pigmentation products.
- Infectious diseases: The inhibitory effect on Helicobacter pylori suggests its application value in the prevention and treatment of gastrointestinal infections.
- Cardiovascular diseases: Cardioprotective effects offer possibilities for treating myocardial ischemia, myocarditis, and other conditions.
- Metabolic diseases: Potential regulatory effects on hyperglycemia-related targets, suggesting research value in diabetes and metabolic syndrome.
Future research should focus on clinical safety evaluation, formulation optimization, and combination therapy strategies for 8-gingerol, while also deeply analyzing its molecular mechanisms to promote its translation from laboratory research to clinical application.
Conclusion
8-Scavengol, as a representative active ingredient in ginger, demonstrates a wide range of biological functions and promising pharmaceutical potential due to its unique chemical structure and diverse pharmacological activities. Its multiple mechanisms of action—antioxidant, anti-inflammatory, antitumor, immunomodulatory, and cardioprotective—provide new ideas for the prevention and treatment of various diseases. Although significant progress has been made in 8-gingerol research, its clinical application still faces challenges due to pharmacokinetic limitations and complex mechanisms.
In the future, it is necessary to strengthen systematic pharmacological research, preclinical safety evaluation, and formulation development of 8-gingerol, integrating modern medicinal chemistry and biotechnology methods to promote its clinical translation. It is believed that as research deepens, 8-gingerol will play an increasingly important role in natural product pharmacology and modern medicine.